SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $241,203 | -98.3% | 1,750 | -98.4% | 0.00% | -97.4% |
| Q4 2022 | $13,903,934 | -8.6% | 107,300 | -22.0% | 0.08% | +9.9% |
| Q3 2022 | $15,205,000 | +13.5% | 137,550 | -23.0% | 0.07% | +44.9% |
| Q2 2022 | $13,392,000 | +27.1% | 178,650 | +32.4% | 0.05% | +32.4% |
| Q1 2022 | $10,538,000 | -50.7% | 134,900 | -43.2% | 0.04% | -49.3% |
| Q4 2021 | $21,378,000 | +5126.9% | 237,400 | +4229.0% | 0.07% | +7200.0% |
| Q1 2021 | $409,000 | -98.6% | 5,484 | -96.7% | 0.00% | -99.0% |
| Q4 2020 | $28,372,000 | +226.6% | 166,415 | +109.0% | 0.10% | +186.1% |
| Q4 2018 | $8,688,000 | +296.9% | 79,610 | +487.5% | 0.04% | +176.9% |
| Q3 2018 | $2,189,000 | +280.0% | 13,551 | +211.2% | 0.01% | +333.3% |
| Q2 2018 | $576,000 | +2.1% | 4,354 | -42.8% | 0.00% | 0.0% |
| Q1 2018 | $564,000 | -25.2% | 7,612 | -43.9% | 0.00% | -50.0% |
| Q4 2017 | $754,000 | – | 13,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |